Results 111 to 120 of about 695,872 (210)
Aim:To determine if PAX-8, CD5, and CD117 can differentiate thymic carcinoma from poorly differentiated lung carcinoma.Design:Archived cases of thymic (n=13) and poorly differentiated lung (n=15) carcinoma were analyzed for intensity and proportion of ...
Asirvatham, J. R. +2 more
core +1 more source
Objectives: Thymic carcinoma (TC) is rare. There is no evidence regarding the treatment strategies for unresectable locally advanced thymic carcinomas. Definitive chemoradiotherapy may treat this condition. However, an appropriate concurrent chemotherapy
Koichiro Nozaki +4 more
doaj +1 more source
Background: Although immune checkpoint inhibitor treatment for advanced thymic carcinoma exhibits promising efficacy, factors that affect the efficacy and prognosis, including metastases sites, remain uncertain. Objectives: Our study aimed to investigate
Yue Hao +10 more
doaj +1 more source
A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma
This case report details a rare thymic basaloid carcinoma initially misinterpreted as a mediastinal teratoma, underscoring the diagnostic challenges posed by such tumors.
Chen Su +3 more
doaj +1 more source
A Case of Well-Differentiated Thymic Carcinoma with Extensive Cystic Degeneration
Thymoma is the most common tumor in the compartment of anterior mediastinum. The malignant thymoma is classified into invasive thymoma(category I) and thymic carcinoma(category II).
안철민
core
Thymic carcinoma: a report of 13 cases
Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosis than thymoma. We report our experience in the treatment of 13 thymic carcinomas.
MUSSI, ALFREDO +6 more
core
Thymic squamous cell carcinoma.
In the case described, a 43-year-old man had an asymptomatic mass involving the right hilar and superior mediastinum. At surgery, the tumor was found to have invaded the right middle lobe of the lung and the pericardium. The mass was found to be a thymic
Himes, B +3 more
core
Macrophage subtypes of anti-PD-1 resistance in thymic carcinoma.
Gene set enrichment analysis of anti-PD 1 treatment for thymic carcinoma showed that patients in complete remission (CR) and partial remission (PR) compared with those in patients with progressive disease (PD).
Liu Xu (472677) +12 more
core +1 more source
Healing of Post-Operative Tracheal Disruption in a Patient with Thymic Carcinoma on Adjuvant Immunotherapy. [PDF]
Lubisich J +7 more
europepmc +1 more source
Cardiac Vigilance Beyond Hypertension With Lenvatinib in Thymic Carcinoma. [PDF]
Gupta A, Gade A, Subedi A.
europepmc +1 more source

